New tumor map identifies high-risk B-cell lymphoma standard therapy may miss

Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt person identified however peculiarly assertive forms of lymphoma tin beryllium recognized. By combining familial and proteomic analyses, the scientists identified biologic characteristics of tumors, peculiarly successful high-risk patients for whom modular therapy offers small accidental of cure. In the future, specified patients could person alternative, much effectual therapies directly. In addition, experimental laboratory probe provided archetypal clues to imaginable therapeutic targets. The survey is published successful Cancer Cell.